Transactions

Closed transactions

Full list of transactions since 2012. Some are disclosed without the company name for confidentiality reasons.

2026

  • 2026TMTSale of a leading Russian company in consumer behaviour and retail market researchSale of businessSell-side
  • 2026TMTSale of a leading Russian provider of retail audit and market analytics solutionsSale of businessSell-side
  • 2026FMCGSale of beverage producer Smart Drinks (Kazakhstan) to Vietnamese group UnibenSmart DrinksUnibenSale of businessSell-side

    Novus Capital acted as financial advisor to the shareholders of Smart Drinks LLP, a Kazakhstan-based producer of canned soft drinks (drinking water, carbonated, juice-based and energy drinks; contract manufacturing capacity of up to 52 million cans a year), on the sale of the business to Uniben, one of Vietnam's leading food and beverage groups. Novus Capital's first transaction in Kazakhstan. Closed in September 2026; terms were not disclosed.

    Counterparty Uniben

  • 2026PackagingSale of a prominent manufacturer of plastic packaging for cosmetics in the Sverdlovsk RegionSale of businessSell-side
  • 2026TMTSale of a leading provider of databases and market research for the pharmaceutical marketSale of businessSell-side
  • 2026MachinerySale of the leading distributor of intralogistics equipment in RussiaSale of businessSell-side

2025

  • 2025TMTSale of omnichannel solutions developer ADV/web-engineering to IT integrator First BitADVПервый БитSale of businessSell-side

    Novus Capital acted as financial advisor to the shareholders of ADV/web-engineering co., a Moscow-based developer of integrated omnichannel solutions for retail and e-commerce (online stores, customer accounts, integrations with back-office systems; clients include TSUM and other major retailers), on the sale of the business to First Bit, an international IT group and the largest 1C integrator in Russia. ADV continues to operate under its own brand within the group. The transaction closed at the turn of 2024 and 2025; terms were not disclosed.

    Counterparty Первый Бит

  • 2025Pharma & HealthcareSale of rights to the drug Armadin LongProduct saleSell-side
  • 2025Pharma & HealthcareSale of a pharmaceutical plant in ChernogolovkaSale of businessSell-side
  • 2025PackagingSale of a company engaged in specialised metalworking for the packaging industrySale of businessSell-side
  • 2025TMTSale of a leading online platform for psychological supportЯсноSale of businessSell-side

    Novus Capital acted as financial advisor to the shareholders of Yasno on the sale of 100% of Yasno.Live LLC to a consortium of private investors. Founded in 2017, Yasno is one of the first and largest online psychotherapy services in Russia, with more than 2,000 psychologists and psychotherapists on the platform and 2024 revenue of RUB 1.1 billion. The transaction closed in November 2025; terms were not disclosed.

    Counterparty Консорциум частных инвесторов

  • 2025FMCGSale of one of the leading players in the Russian household goods marketSale of businessSell-side

2024

  • 2024Pharma & HealthcareSale of a pharmaceutical plantSale of businessSell-side
  • 2024RetailSale of a leading Cash&Carry player and supplier of food products to the HoReCa segmentSale of businessSell-side
  • 2024FMCGSale of a tea producerУниверсальные пищевые технологии (УПТ)Sale of businessSell-side

    Novus Capital acted as financial advisor to the owner of Universal Food Technologies in the sale of the business to a private investor. UFT is one of the leading tea contract manufacturers in Russia.

2023

  • 2023MachinerySale of Oskol Metallurgical Engineering Plant (OZMM) to United Metallurgical Company (OMK)ОЗММОМКSale of businessSell-side

    Novus Capital acted as financial advisor to the principal shareholder of Oskol Metallurgical Engineering Plant (Stary Oskol, Belgorod Region) on the sale of a controlling stake to United Metallurgical Company (OMK). OZMM manufactures grinding media, crushing and milling equipment and other products for mining and processing plants and steelmakers; the transaction closed at the end of 2023.

    Counterparty ОМК

  • 2023EducationSale of online school ProductStar to RBC media holdingProductStarРБКSale of businessSell-side

    Novus Capital acted as financial advisor to the shareholders of ProductStar, an online school teaching remote IT and digital professions, on the sale of 100% of the business to the RBC media holding. The buyer kept ProductStar as a standalone product alongside the RBC.Pro educational unit. The transaction closed in May 2023.

    Counterparty РБК

  • 2023Financial servicesSale of a factoring and leasing businessSale of businessSell-side
  • 2023MachinerySale of an agricultural and construction machinery manufacturing businessSale of businessSell-side
  • 2023Auto componentsSale of an automotive components manufacturing businessSale of businessSell-side
  • 2023TransportSale of a freight railcar leasing businessSale of businessSell-side
  • 2023Pharma & HealthcareSale of a portfolio of Axobrex, Luxidropin, Seltaren, Xedrenio and Ypnomakt products in PolandUnipharmFidiaSale of businessSell-side

    Novus Capital acted as financial advisor to Unipharm in the sale of a portfolio of products well known on the Polish pharmaceutical market. The deal allows Fidia to expand its presence in Europe and enter the Polish market.

    Counterparty Fidia

2022

  • 2022PackagingSale of two speciality cardboard packaging plants and one flexible packaging plantSale of businessSell-side
  • 2022VCCapital raising for Biomicrogel GroupНПО БиомикрогелиCapital raisingSell-side

    Biomicrogel Group is an innovative company established in 2012 by a team of engineers who developed a unique technology for cleaning water and hard surfaces from all types of oils, petroleum products and complex contamination. Novus Capital acted as financial advisor to the founders in raising financing.

  • 2022Electrical equipmentSale of shares in an electrical equipment plantSale of businessSell-side
  • 2022Pharma & HealthcareSale of Ballamin and Streboxar in PolandUnipharmKlosterfrau Healthcare GroupSale of businessSell-side

    Novus Capital acted as sell-side financial advisor to Unipharm in the sale of the Ballamin and Streboxar products to the German company Klosterfrau Healthcare Group.

    Counterparty Klosterfrau Healthcare Group

  • 2022AgricultureSale of the Russian Linen complex to MelkombinatМелькомбинатРусский ЛёнSale of businessSell-side

    Novus Capital acted as financial advisor to the Seller. Our team advised the Seller at all stages of the transaction, in particular in negotiations with buyers, in supporting due diligence and in agreeing binding transaction documentation with several parties in parallel. This transaction is the 37th successfully completed project of Novus Capital.

    Counterparty ОАО «Мелькомбинат»

  • 2022Pharma & HealthcareSale of the antibacterial brands Ciprolet and Levolet in Russia, Belarus and UzbekistanБиннофарм ГруппDr. Reddy'sSale of businessSell-side

    Novus Capital acted as sell-side financial advisor to Dr. Reddy's Laboratories in all phases of the transaction, including preparation of investment materials, negotiations with buyers, support in due diligence and agreeing definitive transaction documentation.

    Counterparty Биннофарм Групп

2021

  • 2021Pharma & HealthcareAcquisition of the Neuromexol productЭндокринные технологииГерофармAcquisitionBuy-side

    Novus Capital acted as financial advisor to Geropharm, a national manufacturer of biotechnological products, in the acquisition of Neuromexol, a product for the treatment of anxiety disorders and autonomic dystonia syndrome.

  • 2021Pharma & HealthcareAmfitaАмфитаSale of businessSell-side

    The company specialises in the development, production and sale of synbiotic preparations based on bifidobacteria and lactobacilli in combination with other biologically active components such as prebiotics, vitamins and minerals. Novus Capital acted as advisor to the sellers in the sale of the business to a group of private investors.

  • 2021Pharma & HealthcareDiaLabДиаЛаб ПлюсCapital raisingSell-side

    DiaLab Plus LLC is a laboratory performing over 2,400 tests across a wide range, from the most common to the rarest (genetics and cytogenetics, immunology and other departments). Novus Capital acted as financial advisor to the founders in raising financing.

  • 2021VCNAYMNAYMCapital raisingSell-side

    An enterprise platform for remote hiring of vetted IT specialists. The company handles sourcing and vetting, making the process of hiring outstanding international teams ten times faster and easier for everyone involved. Novus Capital acted as financial advisor to the founders in raising financing.

  • 2021VCLoshipLoshipCapital raisingSell-side

    Established in 2014, Loship is Vietnam's fastest-growing one-hour-delivery e-commerce startup. The team's mission is to fulfil every instant delivery need of Vietnamese consumers. The company currently runs a fleet of more than 70,000 drivers serving 2 million customers across five major cities in Vietnam. Novus Capital acted as financial advisor to the founders in raising financing.

  • 2021VCVoiceittVoiceittCapital raisingSell-side

    A speech recognition app for people with speech disorders. Designed by experts in algorithms and linguistics, Voiceitt learns the user's unique speech patterns. Using statistical modelling and machine learning, Voiceitt improves every time it is used. Novus Capital acted as financial co-advisor in raising financing.

  • 2021VCRefin.onlineRefin.onlineCapital raisingSell-side

    Refin.online is a Russian fintech startup developing a digital platform for mortgage management. The company helps borrowers refinance mortgages remotely and takes care of all documentation and interaction with the bank. It is an accredited partner of 20 key Russian banks. Novus Capital acted as financial advisor to the founders in raising financing.

  • 2021VCWOWCUBEWOWCUBECapital raisingSell-side

    A US company that created the miniature WOWCUBE game cube, reminiscent of the Rubik's Cube, and an ecosystem for developing, publishing and selling applications for it. The device is equipped with 8 microprocessors and 24 screens, and applications can be loaded from an iOS or Android smartphone via Bluetooth. Novus Capital acted as financial advisor to the founders in raising financing.

  • 2021VCEssense Investment AGEssense Investment AGCapital raisingSell-side

    A Swiss cannabis holding with 50+ years of combined experience in research, product development, brand and marketing, distribution and retail, including phyto-pharmaceuticals and wellness. Essense Investment AG invests in and develops companies and technologies related to the cannabis industry. Novus Capital acted as financial advisor to the founders in raising financing.

  • 2021VCAngaraАнгараCapital raisingSell-side

    A pioneer in cognitive cleaning technology, Angara helps its clients meet net-zero emissions targets and improve processing margins by reducing fossil fuel energy use through boosting the performance of heat exchange equipment. Novus Capital acted as financial advisor to the founders in raising financing.

  • 2021VCMyosMyosCapital raisingSell-side

    Myos acts as a financial investor for German and Austrian companies selling their products online. Since 2018, the company has successfully funded and helped develop more than 1,000 businesses. Novus Capital acted as financial advisor to the founders in raising financing.

  • 2021VCAripix RoboticsAripix RoboticsCapital raisingSell-side

    Aripix Robotics is a Russian company specialising in the development, production and installation of 6-axis industrial robotic arms for small, medium and large enterprises worldwide. The robots automate cyclical routine operations in factories, increase production efficiency and raise labour productivity. Novus Capital acted as financial advisor to the founders in raising financing.

  • 2021VCCarouselКарусельCapital raisingSell-side

    Carousel is a Russian electric scooter sharing company offering uniquely durable scooters with a long range (up to 40 km on a single charge). The company is currently present in five Russian cities. Novus Capital acted as financial advisor to the founders in raising financing.

2020

  • 2020Pharma & HealthcareSale of the nasal sprays Momat Rino and Momat Rino AdvanceDr. Reddy'sGlenmarkSale of businessSell-side

    Novus Capital acted as financial advisor to Glenmark Pharmaceuticals and organised a highly competitive closed auction process. In line with its strategy to launch Ryaltris, its global anti-allergy brand, in Russia and other CIS markets, Glenmark Pharmaceuticals decided to divest the Momat Rino brand and its extensions in Russia, Ukraine, Kazakhstan and Uzbekistan.

    Counterparty Dr. Reddy's Laboratories

  • 2020Pharma & HealthcareEquity financing for ASNA GroupГазпромбанкАСНАCapital raisingSell-side

    Novus Capital acted as financial advisor to ASNA Group in raising equity financing from JSC Gazprombank. ASNA Group is the No. 1 player in Russian pharmaceutical retail, uniting approximately 11,500 independent pharmacies.

    Counterparty Газпромбанк

  • 2020Pharma & HealthcareSale of Teva Pharmaceuticals' plant in RussiaР-ФармTevaSale of businessSell-side

    Novus Capital acted as financial advisor to Teva Pharmaceuticals in sourcing buyers and facilitating negotiations with them. Teva Pharmaceuticals decided to sell its pharmaceutical plant in Russia (Yaroslavl) as part of a broader programme to restructure its production infrastructure.

  • 2020VCRADLogicsRADLogicsCapital raisingSell-side

    RADLogics develops AI-powered solutions that support image analysis to improve radiologists' productivity while enhancing patient outcomes. Novus Capital acted as financial advisor to the founders in raising Series B financing.

  • 2020VCLOLOCLOLOLOCLOCapital raisingSell-side

    LOLOCLO is a Russian startup showing rapid growth in the children's clothing segment. The company manufactures and sells a complete basic wardrobe for children aged 0 to 12 using a direct-to-consumer model. Novus Capital acted as financial advisor to the founders in raising Series A financing.

  • 2020VCPolyn TechnologyPolyn TechnologyCapital raisingSell-side

    Polyn Technology is a high-tech startup that developed a mathematical algorithm for converting almost any trained neural network into a package of technical documentation and then "printing" the network on silicon as a neuromorphic analog chip. Novus Capital acted as financial advisor to the founders in raising seed financing.

  • 2020VCPrivate placement and capital raise for GenotekГенотекCapital raisingSell-side

    Novus Capital acted as financial advisor to the shareholders of Genotek, one of the leading DNA testing companies in Russia, in a capital raise and private placement.

2019

  • 2019Pharma & HealthcareDivestiture of the Oralsept product line to Gedeon Richter PlcGedeon RichterОралсептSale of businessSell-side

    Novus Capital acted as financial advisor to Salvim LLC in the transaction. Following negotiations, in November 2019 Salvim LLC and Gedeon Richter Plc signed an agreement on the sale of rights to the Oralsept product line.

    Counterparty Gedeon Richter Plc

  • 2019Pharma & HealthcareAcquisition of a product from Profit PharmПрофит ФармUnipharmAcquisitionBuy-side

    Novus Capital acted as financial advisor to Unipharm, a leading regional OTC company, in the acquisition of a melatonin-based product on the Russian market from Profit Pharm.

    Counterparty Профит Фарм

2018

  • 2018Pharma & HealthcareSale of a stake in Active Component to Elbrus CapitalElbrus CapitalАктивный КомпонентSale of businessSell-side

    Novus Capital acted as financial advisor to the owners of Active Component in the sale of a stake to the private equity fund Elbrus Capital. Active Component is the leading manufacturer of active pharmaceutical ingredients in Russia.

    Counterparty Elbrus Capital

2017

  • 2017Pharma & HealthcareSale of ALSI Pharma to Xantis PharmaXantis PharmaАЛСИ ФармаSale of businessSell-side

    Novus Capital acted as financial advisor to the owners of the Russian company ALSI Pharma in the sale to the strategic investor Xantis Pharma. ALSI Pharma is a leading generics manufacturer in Russia, specialising in cardiovascular and central nervous system products.

    Counterparty Xantis Pharma

2016

  • 2016Pharma & HealthcareDivestiture of the Dolphin brand portfolio to AlvogenAlvogenДолфинSale of businessSell-side

    Novus Capital acted as financial advisor to the owners of the Dolphin product line, a leading over-the-counter product (medical device) for the treatment of sinusitis in Russia, in the sale of the business to the US company Alvogen.

    Counterparty Alvogen

2015

  • 2015Pharma & HealthcareSale of the ORVIREM brand to AlvogenAlvogenОРВИРЕМProduct saleSell-side

    The Novus Capital team advised the shareholders of the Russian pharmaceutical company Diod on the sale of the rights to the cold remedy ORVIREM to the US company Alvogen.

    Counterparty Alvogen

  • 2015Pharma & HealthcareAcquisition of a manufacturing site in LithuaniaValeant Pharmaceuticals InternationalMateria MedicaAcquisitionBuy-side

    The Novus Capital team advised the shareholders of the Russian company Materia Medica on the acquisition of a pharmaceutical manufacturing site in Lithuania from Valeant Pharmaceuticals International.

    Counterparty Valeant Pharmaceuticals International

  • 2015TMTJoint venture between Aaron Lloyd and Dentsu Aegis NetworkDentsu Aegis NetworkAaron LloydSale of businessSell-side

    Novus Capital acted as financial advisor to Aaron Lloyd, a leading Russian pharmaceutical communications agency, on setting up a joint venture in Russia with the global communications group Dentsu Aegis Network.

    Counterparty Dentsu Aegis Network

2014

  • 2014Pharma & HealthcareSale of the Aqualor brand to STADA for USD 180 millionSTADA ArzneimittelАквалорSale of businessSell-side

    Novus Capital partners acted as financial advisors to the owner of Aqualor, a leading over-the-counter nasal irrigation product in Russia, on its sale to the German company STADA Arzneimittel.

    Counterparty STADA Arzneimittel

2012

  • 2012Pharma & HealthcareSale of the Akvion product portfolio to RecordatiRecordatiАквионSale of businessSell-side

    Novus Capital partners acted as financial advisors to the owners of Akvion, a leading Russian maker of dietary supplements, on the sale of its product portfolio to the Italian company Recordati.

    Counterparty Recordati

  • 2012TMTSale of Pharmexpert intellectual property to IMS HealthIMS HealthФармэкспертSale of businessSell-side

    Novus Capital partners acted as financial advisors to the owners of Pharmexpert, a leading provider of analytics to pharmaceutical companies in Russia, on structuring and closing the transaction with IMS Health, the global leader in pharmaceutical market information.

    Counterparty IMS Health

Discuss a mandate

Leave your contacts and a short description of the task. We reply within one business day.

Preferred way to reach you